.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Covington
Mallinckrodt
Fuji
Johnson and Johnson
Novartis
Dow
Cerilliant
US Army

Generated: December 15, 2017

DrugPatentWatch Database Preview

Drug Master Files for: moexipril

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
9942III11/6/1992PCASMOEXIPRIL HYDROCHLORIDE
10520III9/30/1993ORGAMOL SAMOEXIPRIL HYDROCHLORIDE
15172AII12/6/2000ESTEVE QUIMICA SAMOEXIPRIL HYDROCHLORIDE
16670III6/25/2003UCB MANUFACTURING IRELAND LTDMOEXIPRIL HYDROCHLORIDE
17840AII11/19/2004FARMHISPANIA SAFH-109 (MOEXIPRIL HYDROCHLORIDE)
19113AII1/18/2006APOTEX PHARMACHEM INCMOEXIPRIL HYDROCHLORIDE USP
20426AII4/9/2007GLENMARK PHARMACEUTICALS LTDMOEXIPRIL HYDROCHLORIDE USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
UBS
US Army
Julphar
McKinsey
Boehringer Ingelheim
Fish and Richardson
Teva
QuintilesIMS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot